Atrium Health, Cleveland Clinic and MemorialCare Health System expanded the round, which already featured McKesson Ventures, Novartis, Philips, ResMed and Providence Ventures, by $3m.

Stanford's Atreca floated in the middle of its range and will use the funding to advance its lead cancer immunotherapeutic canadidate through the clinic.

GSK-backed Atreca floated in the middle of its range and will use the funding to advance its lead cancer immunotherapeutic canadidate through the clinic.

The cardiac imaging system developer secured $100m in a GE Ventures-backed series D round in addition to $70m in debt financing.

The gene therapy developer has boosted its initial public offering, which gave an exit to Alexandria Real Estate Equities, to more than $163m in size.

National Bank of Canada contributed to a $29.8m round that will fund the virtual healthcare platform's expansion in Europe.

Lab10x will accelerate the commercialisation of digital therapeutics and data-driven drug discovery, and is being launched in partnership with Sensyne Health and Evotec.

Taiho Ventures has supplied a $10m extension for Caltech spinout Axial Biotherapeutics’ series B, bringing the total to $35m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.